Effects of the combination therapy of irbesartan and indapamide in chronik kidney disease with hypertensio
Phase 4
- Conditions
- chronick kidney disease with hypertension
- Registration Number
- JPRN-UMIN000010787
- Lead Sponsor
- Division of Nephrology, Department of Internal medicine, Jichi Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)chronik kidney disease udergoing hemodialysis or peritoneal dialysis 2)acute kindey injury 3)severe heart failure 4)type I or type II diabetes mellitus with poor glucose control (serum glycosylated hemoglobin [HbA1c] level > 9%) 5)severe liver dysfunction 6)hyperkalemia (> 5.5 mEq/ml) 7)pregnant women 8)patinets who will not give informed concent
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of blood pressure, heart function, renal function
- Secondary Outcome Measures
Name Time Method